Loading…
Loading…
SYRA does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SYRA and 80,000+ other tickers.
See exactly how SYRA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SYRA and 80,000+ other tickers.
Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing…
Syra Health sustained profitability in Q2 2026, following the Company's first profitable quarter in Q1 2026, delivering net income of $250,242 compared with a net loss of $(63,596) in the prior-year period. Q2 2026 revenue grew 23% year-over-year to $2.4 million.
CARMEL, Ind., Aug. 4, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for the three months ended June 30, 2026, on Tuesday, August 11, 2026.
Syra Health Corp. (NASDAQ: SYRA - Get Free Report) dropped 4.3% during mid-day trading on Wednesday. The company traded as low as $0.7610 and last traded at $0.7610. Approximately 5,296 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 50,661 shares. The stock had previously closed at $0.7952.
CARMEL, Ind., July 7, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer.
Syra Health delivered its first-ever profitable quarter in Q1 2026, with net income of approximately $241,000, representing a substantial 151% increase over the year-ago period Q1 2026 EPS grew to $0.02 per share versus ($0.04) in Q1 2025 Gross Margin rose to 42.7%, up 11 percentage points year-over-year Total revenue increased to $2.3 million, up 22% when compared to the prior year period CARMEL, Ind., May 7, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the first quarter ended March 31, 2026.